-
2025-522091-84-00
4
2026-05-29
Merkel Cell Carcinoma
-
2025-522107-18-00
4
2026-05-19
Locally advanced or metastatic Non-Small Cell Lung Cancer
-
2025-523602-33-00
9
2026-05-13
Advanced or unresectable Hepatocellular Carcinoma (HCC)
-
2025-520452-28-00
4
2026-05-12
Recurrent urinary tract infections (rUTI)
-
2025-523938-10-00
5
2026-05-05
Diabetic Macular Edema (DME)
-
2022-501458-13-01
4
2026-04-29
Advanced Stage of Classic Hodgkin Lymphoma
-
2025-522567-15-00
5
2026-04-28
Plaque Psoriasis
-
2025-523717-29-00
5
2026-04-28
HFpEF or HFmrEF and obesity
-
2025-523079-44-00
5
2026-04-15
Turner Syndrome (TS)
-
2024-520101-39-00
5
2026-04-01
TROP2 NMR-positive advanced or metastatic non-squamous non-small cell
-
2025-522402-21-00
1
2026-03-27
Advanced solid tumors (cutaneous melanoma, mucosal melanoma, cutaneous
-
2025-523533-25-00
10
2026-03-26
Cancer-associated Cachexia
-
2023-504957-11-00
5
2026-03-24
Metastatic castration resistant prostate cancer
-
2024-515635-30-00
3
2026-03-24
Coagulopathy
-
2025-521416-19-00
4
2026-03-12
Recurrence of Clostridioides difficile Infection
-
2025-520675-86-00
4
2026-03-10
Unresectable or Metastatic Hepatocellular Carcinoma and Compensated Li
-
2025-521284-12-00
5
2026-03-05
Non-small cell lung cancer
-
2024-516216-16-00
5
2026-02-13
Invasive mold infections caused by Aspergillus spp., Fusarium spp., Lo
-
2024-516966-12-00
4
2026-02-13
Alzheimer’s disease
-
2025-521124-29-00
10
2026-02-13
Non-Small Cell Lung Cancer
-
2025-523846-29-00
1
2026-02-09
HIV-1 infection
-
2024-517238-16-00
5
2026-01-28
Hypochondroplasia
-
2024-519748-34-00
4
2026-01-23
Infections with multidrug-resistant Enterobacteriaceae
-
2023-507879-21-00
4
2026-01-19
AML and MDS undergoing allogeneic Transplantation